![Investigation of the effects of Simvastatin and other statin drugs on gut Microbiome with regards to clinical obesity ,[object Object],[object Object],[object Object],[object Object],[object Object]](https://image.slidesharecdn.com/statins-talk-2009-1231481227803286-1/85/Statins-Talk-2009-1-320.jpg)
![Outline ,[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Recommended
More Related Content
What's hot
What's hot (20)
Similar to Statins Talk 2009
Similar to Statins Talk 2009 (20)
Recently uploaded
Recently uploaded (20)
Statins Talk 2009
- 8. R R R S S Fimicute Clostridium sordellii See Fig. 3 and comments. R: Resistant, little or no zone of inhibition; S: susceptible, clear zone of inhibition; s: slightly susceptible, hazy zone of inhibtion S S S S S Fungi Candida albicans R R R R R Enterobacteria E. aerogenes R R R R R Enterobacteria S. marcescens R R s R R Enterobacteria K. pneumoniae R R s s s Fimicute S. epidemidis R R S S S Enterobacteria E. coli R R S S S Fimicute S. aureus (MRSA&MSSA) s S S S S Enterobacteria P. mirabilis R S S S S Fimicute B. subtilis Crestor Lovastatin Lipitor Fluvastatin Zocor Taxonomic group Species Table 1. Variable susceptibilities of bacterial species to individual statins by agar-based assay
- 9. Bacillus subtilis 6633-1 Bacillus subtilis Zocor Lovastatin Lovastatin (1:10) Zocor (1:10) Fluvastatin Fluvastatin (1:10)
- 10. Clostridium sordellii 9714-1 Clostridium sordellii Zocor Lovastatin Lovastatin (1:10) Zocor (1:10) Fluvastatin Fluvastatin (1:10)